The present invention generally relates to methods of identifying modulators of central nervous system diseases and the use of the modulators in treatment and diagnosis. The methods utilize a novel high throughput screen that includes injection of a library of barcoded viral vectors expressing shRNAs, CRISPR/Cas systems or cDNAs into animal models of disease and detecting synthetic lethality.